ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SVS Solarvest BioEnergy Inc

0.025
0.00 (0.00%)
29 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Solarvest BioEnergy Inc TSXV:SVS TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.025 0.025 0.025 0 01:00:00

Solarvest BioEnergy Inc. Announces Amended and Restated Interim Financial Statements and Management Discussion and Analysis f...

30/07/2012 10:31pm

Marketwired Canada


As a result of a review by the British Columbia Securities Commission ("BCSC"),
- SOLARVEST BIOENERGY INC (TSX VENTURE:SVS) ("Solarvest" or the "Company") is
issuing the following press release to clarify our disclosure. 


Solarvest today filed on SEDAR amended and restated interim financial
statements, together with an amended and restated Management Discussion and
Analysis ("MD&A"), for the period ended April 30, 2012. 


The BCSC has completed its review of the Company's interim financial statements
and MD&A for the three months ended April 30, 2012, which were originally filed
on June 29, 2012. The results of the review can be summarized as follows: the
amended and restated interim financial statements update the presentation of
certain information in compliance with IAS and IFRS requirements and now provide
additional disclosure with respect to the Company's operations, including
related party transactions, the commitment to issue shares as related to its
intellectual property development milestones and the ongoing analysis of the
value of its intellectual property. The amended and restated MD&A revises the
presentation of certain information in compliance with National Instrument
51-102 - Continuous Disclosure Obligations and now provides additional
disclosure with respect to research & development costs and related party
transactions. 


In addition, the Company has filed updated certificates of the Chief Executive
Officer and the Chief Financial Officer for the interim period ended April 30,
2012, as required under National Instrument 52-109 - Certification of Disclosure
in Issuers' Annual and Interim Filings.


About Solarvest: Solarvest is committed to the development of sustainable and
renewable energy sources to meet growing energy demands and environmental
challenges. Solarvest's intellectual property is a biologically-based hydrogen
producing technology, which provides a method for controlling key genes in algae
resulting in the continuous production of hydrogen gas. Solarvest's bio-energy
production system utilizes light and carbon dioxide to produce hydrogen leaving
a clean positive environmental footprint.


The statements made in this news release may contain forward-looking statements
that may involve a number of risks and uncertainties. Actual events or results
could differ materially from the Company's expectations and projections.


1 Year Solarvest BioEnergy Chart

1 Year Solarvest BioEnergy Chart

1 Month Solarvest BioEnergy Chart

1 Month Solarvest BioEnergy Chart

Your Recent History

Delayed Upgrade Clock